ABK BIOMEDICAL INCORPORATED
$314,512.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- May 5, 2025 – August 3, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q1-1030534
Published purpose
This project aims to develop resorbable hollow/porous/solid glass microspheres for precision transarterial embolization (TAE), with long-term variants as an additional option. Unlike permanent embolic agents, the resorbable radiopaque microspheres provide temporary occlusion, precise imaging, and safe, controlled degradation. Objectives include synthesizing tunable glass microsphere compositions, optimizing their structure for payload and delivery efficiencies, and confirming effectiveness in preclinical models. These versatile, biocompatible microspheres enhance TAE precision, minimize long-term risks for temporary embolization needs, and set a new benchmark in interventional radiology.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.